Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Dexamethasone could be more effective than prednisolone at similar anti-inflammatory doses in the treatment of childhood acute lymphoblastic leukemia. In order to check if this “superiority” of dexamethasone might be dose-dependent, we conducted a randomized phase III trial comparing dexamethasone (...

Full description

Bibliographic Details
Published in:	Haematologica
Main Authors:	Carine Domenech, Stefan Suciu, Barbara De Moerloose, Françoise Mazingue, Geneviève Plat, Alina Ferster, Anne Uyttebroeck, Nicolas Sirvent, Patrick Lutz, Karima Yakouben, Martine Munzer, Pierre Röhrlich, Dominique Plantaz, Frederic Millot, Pierre Philippet, Nicole Dastugue, Sandrine Girard, Hélène Cavé, Yves Benoit, Yves Bertrandfor, Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC)
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2014-07-01
Online Access:	https://haematologica.org/article/view/7087

Similar Items

Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
by: Veerle Mondelaers, et al.
Published: (2017-10-01)

CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol
by: Farzaneh Ghazavi, et al.
Published: (2015-10-01)

Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B‐ and T‐cell acute lymphoblastic leukemia
by: Carine Domenech, et al.
Published: (2024-11-01)

Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studies
by: Maëlle de Ville de Goyet, et al.
Published: (2024-01-01)

Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
by: Audrey Valdes, et al.
Published: (2018-06-01)

Comparison of 2.0 mg/kg/day and 0.5 mg/kg/day immunosuppressive dexamethasone protocols as initial treatment for dogs with MUO
by: Miroslav Prikryl, et al.
Published: (2025-06-01)

The efficacy and tolerability of 10mg and 20mg/day isotretinoinin the treatment of acne vulgaris in Iraqi patients
by: Galawish A. Abdullah
Published: (2013-01-01)

Saussure e seu CLG (curinga da linguística geral)
by: Karen Andresa Santorum, et al.
Published: (2020-05-01)

CLG: Contrastive Label Generation with Knowledge for Few-Shot Learning
by: Han Ma, et al.
Published: (2024-02-01)

In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 mg/day is as Effective as Standard Dose of 800 mg/day in Patients with Advanced Hepatocellular Carcimona, with Better Tolerance and Similar Survival
by: Alexandra Shingina, et al.
Published: (2013-01-01)

Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial
by: Stephen B Hanauer, et al.
Published: (2007-01-01)

P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.
by: Dan Yu, et al.
Published: (2023-08-01)

Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
by: Pierre Paré, et al.
Published: (1990-01-01)

What Is the Role of Beta-Agonist Bronchodilators in the Day-to-Day Treatment of Chronic Asthma?
by: Pierre Ernst
Published: (1995-01-01)

Impact of 1.0 mg/Day Dienogest Treatment on Bone Metabolism Markers in Young Women with Dysmenorrhea
by: Ikuko Ota, et al.
Published: (2021-08-01)

Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study.
by: Vladimir A Parfenov, et al.
Published: (2017-01-01)

Intragastric pH effect of 20 mg of levo-pantoprazole versus 40 mg of racemic pantoprazole the first seven days of treatment in patients with gastroesophageal reflux disease
by: J.M. Remes-Troche, et al.
Published: (2020-01-01)

Preservation without Representation: Making CLG Programs Vehicles for Inclusive Leadership, Historic Preservation, and Engagement
by: Andrea R. Roberts
Published: (2020-08-01)

P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma
by: Hannah Moatti, et al.
Published: (2022-10-01)

Iron Supplementation at 1 mg/kg/Day for Exclusively Breastfed Full-Term Infants: A Meta-Analysis
by: Suyu Wang, et al.
Published: (2025-01-01)

Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor
by: Silke Cameron, et al.
Published: (2011-10-01)

Michael P. Kramer. New Essays on Bellow’s Seize the Day.
by: Jean-Yves Pellegrin
Published: (2006-04-01)

Analysis of the symptom response to esomeprazole 20 mg over days 1–4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials
by: David Peura, et al.
Published: (2019-08-01)

PB1758: TWENTY-ONE YEARS’ EXPERIENCE OF THE EORTC 58951 PROTOCOL FOR THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA
by: I. Frikha, et al.
Published: (2022-06-01)

PB2286: EVALUATION OF THE THERAPEUTIC RESULTS OF LYMPHOBLASTIC LYMPHOMA TREATED ACCORDING TO THE EORTC 58951 PROTOCOL IN CHILDREN ADOLESCENTS AND YOUNG ADULTS
by: Hana Ben Hammamia, et al.
Published: (2023-08-01)

Antiplatelet Efficacy of 75 mg Aspirin Once a Day versus Twice a Day Dosing in Type 2 Diabetes Mellitus Patients- A Longitudinal Open Label Study
by: Mayur B Phulpagare, et al.
Published: (2022-11-01)

P398: HIGH-RISK CHILDHOOD AND ADOLESCENT AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE EORTC 58951 PROTOCOL: RESULTS AND OUTCOME
by: Imen Frikha, et al.
Published: (2023-08-01)

Pharmacokinetics of acetaminophen after a single Oral administration of 20 or 40 mg/kg to 7–9 Day-old foals
by: Jenifer R. Gold, et al.
Published: (2023-07-01)

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study
by: Dunbar Lala M, et al.
Published: (2005-05-01)

Open prospective study to evaluate the efficacy of a new vaginal pessary containing 300mg tinidazole, 200mg tioconazole and 100mg lidocaine with a 3-day regime (Gynomax XL®) in the treatment of vaginal infections due to bacterial vaginosis, candidiasis an
by: P.A. Regidor, et al.
Published: (2024-03-01)

Woolf’s Exploration of —Combinations: Feminism in Night and Day
by: Nicolas Pierre Boileau
Published: (2020-03-01)

Modeling the impact of changes in day-care contact patterns on the dynamics of varicella transmission in France between 1991 and 2015.
by: Valentina Marziano, et al.
Published: (2018-08-01)

CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
by: Luigi Portella, et al.
Published: (2024-08-01)

Pharmacokinetics, pharmacodynamics and safety of 15 mg-tolvaptan administered orally for 7 consecutive days to Chinese patients with child-Pugh B cirrhosis
by: Hongzhong Liu, et al.
Published: (2024-01-01)

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
by: Peter Kamstrup, et al.
Published: (2023-07-01)

Investigations on the Effect of Pre-Treatment of Wheat Straw on Ash-Related Issues in Chemical Looping Gasification (CLG) in Comparison with Woody Biomass
by: Florian Lebendig, et al.
Published: (2022-05-01)

Complete genome sequencing of Peyer’s patches-derived Lactobacillus taiwanensis CLG01, a potential probiotic with antibacterial and immunomodulatory activity
by: Xiao-yu Li, et al.
Published: (2021-02-01)

Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double‐Blind, Multicenter Study
by: Moura Revueltas Aguero, et al.
Published: (2025-10-01)

Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
by: Moura Revueltas, et al.
Published: (2025-04-01)

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide
by: Suehiro M, et al.
Published: (2021-02-01)